Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Svas Biosana SpAMIL:SVS 79 Days Payable is 155.38 as of Dec. 2025, which is 2% above its 10-year median of 151.86. GuruFocus rates MIL:SVS with a GF Score™ of 79/100 and a GF Value™ of €9.61 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Svas Biosana SpA ranks better than 75.94% on this metric.
The historical rank and industry rank for Svas Biosana SpA's Days Payable or its related term are showing as below:
MIL:SVS'
s Days Payable Range Over the Past 10 Years
Min: 104.86 Med: 151.86 Max: 190.64
Current: 139.16
During the past 8 years, Svas Biosana SpA's highest Days Payable was 190.64. The lowest was 104.86. And the median was 151.86.
MIL:SVS's Days Payable is ranked better than 75.94% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 68.615
vs MIL:SVS: 139.16
Svas Biosana SpA's Days Payable
increased
from Dec. 2024 (133.64) to Dec. 2025 (155.38).
It may suggest that Svas Biosana SpAdelayed paying its suppliers.
The historical data trend for Svas Biosana SpA's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Svas Biosana SpA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Svas Biosana SpA Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Svas Biosana SpA's Days Payable distribution charts can be found below:
* The bar in red indicates where Svas Biosana SpA's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Svas Biosana SpA's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Svas Biosana SpA (MIL:SVS) has a Days Payable of 155.38 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Svas Biosana SpA and its competitors. This is near median its historical median of 151.86. Over the past decade, Svas Biosana SpA's Days Payable has ranged from 104.86 to 190.64. According to the industry distribution chart, Svas Biosana SpA ranks #191 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 24.1%.
Is Svas Biosana SpA's Days Payable too high?
Svas Biosana SpA's current Days Payable of 155.38 is near median its 10-year median of 151.86. Over the past 10 years, this metric has ranged from a low of 104.86 to a high of 190.64. The Medical Devices & Instruments industry median Days Payable is 68.62. Svas Biosana SpA's value of 155.38 is 126.5% above this industry median. Based on the distribution chart, Svas Biosana SpA ranks #191 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Svas Biosana SpA has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Svas Biosana SpA's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Svas Biosana SpA ranks #191 out of 794 companies for Days Payable. This places Svas Biosana SpA in the top 24% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.62. Svas Biosana SpA's value of 155.38 is 126.5% above this benchmark. Historically, Svas Biosana SpA's own Days Payable has ranged from 104.86 to 190.64 over the past decade. While the company's 10-year median is 151.86 vs. the industry median of 68.62, Svas Biosana SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.62, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Svas Biosana SpA's current Days Payable of 155.38 is 126.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Svas Biosana SpA and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Svas Biosana SpA's current Days Payable is 155.38, which is near median its own 10-year median of 151.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Svas Biosana SpA stock overvalued right now?
Based on GuruFocus' analysis, Svas Biosana SpA (MIL:SVS) is currently considered Modestly Undervalued. The stock's GF Value™ is €9.61, compared to a current price of €8.38 — trading 12.8% below its estimated fair value. The current Days Payable is 155.38, which is near median its 10-year median of 151.86 and 126.5% above the Medical Devices & Instruments industry median of 68.62. Svas Biosana SpA's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Svas Biosana SpA (MIL:SVS), the current Days Payable is 155.38 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Svas Biosana SpA (MIL:SVS) Overvalued in 2026?
Based on GuruFocus' analysis, Svas Biosana SpA stock appears to be undervalued.
The current stock price of €8.38 is trading 12.8% below its estimated GF Value™ of €9.61.
GuruFocus considers Svas Biosana SpA to be Modestly Undervalued.
Key valuation signals for MIL:SVS:
Days Payable: 155.38 (near median its 10-year median of 151.86)
GF Value™: €9.61 vs. price of €8.38 (12.8% below fair value)
Industry Position: 126.5% above the Medical Devices & Instruments median (#191 of 794)
No single metric tells the full story. See the MIL:SVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:SVS has been successfully added to your 
